Gabather AB

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: SE0010869552

SEK

0.03

-0.01 (-30.38%)

Dec 04

OME

Click here to see other stocks

Company CV

About Gabather AB

stock-summary

Gabather AB

Pharmaceuticals & Biotechnology

Gabather AB is a Sweden-based company engaged pharmaceutical industry. The Company develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The Company mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.

Company Coordinates

Company Details

Skeppsbron 2, 1 TR , MALMO None : 211 20

stock-summary

Tel: 46 46 2863600

stock-summary

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Board of Directors

Management

Designation

Mr. Svein Mathisen

Independent Chairman of the Board

Mr. Mogens Nielsen

Director

Dr. Gunilla Ekstrom

Independent Director

Mr. Lars Persson

Independent Director

Prof. Olov Sterner

Independent Director

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 8 Million ()

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

3.00

Return on Equity

446.40%

Price to Book

-7.70